The meaning of R1 resection after endoscopic removal of gastric, duodenal and rectal neuroendocrine tumors

被引:8
作者
Esposito, Gianluca [1 ]
Dell'Unto, Elisabetta [1 ]
Ligato, Irene [1 ]
Marasco, Matteo [1 ]
Panzuto, Francesco [1 ,2 ]
机构
[1] Sapienza Univ Rome, St andrea Univ Hosp, ENETS Ctr Excellence, Dept Med Surg Sci,Translat Med,Digest Dis Unit, Rome, Italy
[2] Sapienza Univ Rome, St Andrea Univ Hosp, Dept Med Surg Sci & Translat Med, Via Grottarossa 1035, I-00189 Rome, Italy
关键词
endoscopy; neuroendocrine tumors; stomach; rectum; duodenum; tumor progression; residual disease; polypectomy; CARCINOID-TUMORS; MUCOSAL RESECTION; SUBMUCOSAL DISSECTION; TREATMENT OUTCOMES; CLINICAL-OUTCOMES; NON-AMPULLARY; RISK-FACTORS; FOLLOW-UP; MANAGEMENT; EFFICACY;
D O I
10.1080/17474124.2023.2242261
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
IntroductionWell-differentiated gastric, duodenal, and rectal neuroendocrine neoplasms (NETs) are rare diseases usually managed by endoscopic treatment. Although several endoscopic techniques are available, the number of patients with incomplete (R1) resection is significant.Areas coveredThis review focuses on the meaning of incomplete R1 findings after endoscopic resection in type I gastric NETs; nonfunctioning, non-ampullary duodenal NETs; and small rectal NETs. Data were identified by MEDLINE database search without publication date limitation.Expert opinionAn incomplete R1 finding may have no significant impact on a patient's clinical outcome, particularly in small G1 type I gastric NETs, which have an indolent course. A 'stepwise approach,' which uses more advanced endoscopic techniques, or minimally invasive surgery may be justified to achieve complete margin-free resection. This approach must balance the tumor features and the procedure-related risk of complications, particularly in the duodenum, where the role of deep endoscopic resections is limited due to the thin duodenal wall. Gastric and rectal NETs that are incompletely removed after initial resection are more easily amenable to deep endoscopic techniques. However, this might not be necessary for patients with comorbidities, elderly, or both due to the uncertainty of how R1 finding impacts a patient's clinical outcome.
引用
收藏
页码:785 / 793
页数:9
相关论文
共 61 条
  • [1] ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors
    Borbath, Ivan
    Pape, Ulrich-Frank
    Deprez, Pierre H.
    Bartsch, Detlef Klaus
    Caplin, Martyn
    Falconi, Massimo
    Garcia-Carbonero, Rocio
    Grozinsky-Glasberg, Simona
    Jensen, Robert T.
    Arnold, Rudolf
    Ruszniewski, Philippe
    Toumpanakis, C.
    Valle, Juan W.
    Toole, Dermot O.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 (03)
  • [2] Comparison of endoscopic resection techniques for duodenal neuroendocrine tumors: systematic review
    Brito, Helcio Pedrosa
    Torres, Isabela Trindade
    Turke, Karine Corcione
    Parada, Artur Adolfo
    Waisberg, Jaques
    Botelho, Ricardo Vieira
    [J]. ENDOSCOPY INTERNATIONAL OPEN, 2021, 09 (08) : E1214 - E1221
  • [3] Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study
    Campana, Davide
    Ravizza, Davide
    Ferolla, Piero
    Faggiano, Antongiulio
    Grimaldi, Franco
    Albertelli, Manuela
    Berretti, Debora
    Castellani, Danilo
    Cacciari, Giulia
    Fazio, Nicola
    Colao, Annamaria
    Ferone, Diego
    Tomassetti, Paola
    [J]. ENDOCRINE, 2016, 51 (01) : 131 - 139
  • [4] Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors
    Cha, Jae Hwang
    Jung, Da Hyun
    Kim, Jie-Hyun
    Youn, Young Hoon
    Park, Hyojin
    Park, Jae Jun
    Um, Yoo Jin
    Park, Soo Jung
    Cheon, Jae Hee
    Kim, Tae Il
    Kim, Won Ho
    Lee, Hyun Jung
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Clinical Impact of Endoscopic Submucosal Dissection for Gastric Neuroendocrine Tumors: A Retrospective Study from Mainland of China
    Chen, Wei-Feng
    Zhou, Ping-Hong
    Li, Quan-Lin
    Xu, Mei-Dong
    Yao, Li-Qing
    [J]. SCIENTIFIC WORLD JOURNAL, 2012,
  • [6] Efficacy and safety of endoscopic submucosal dissection for gastrointestinal neuroendocrine tumors: a 10-year data analysis of Northern China
    Chen, Xin
    Li, Bianxia
    Wang, Saiyu
    Yang, Bo
    Zhu, Lanping
    Ma, Shuang
    Wu, Jingyi
    He, Qijin
    Zhao, Jingwen
    Zheng, Zhongqing
    Li, Shu
    Wang, Tao
    Liang, Li
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2019, 54 (03) : 384 - 389
  • [7] Outcomes of Surgical and Endoscopic Resection of Duodenal Neuroendocrine Tumours (NETs): a Systematic Review of the Literature
    Dasari, Bobby V. M.
    Al-Shakhshir, Sarah
    Pawlik, Timothy M.
    Shah, Tahir
    Marudanayagam, Ravi
    Sutcliffe, Robert P.
    Mirza, Darius F.
    Muiesan, Paolo
    Roberts, Keith J.
    Isaac, John
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2018, 22 (09) : 1652 - 1658
  • [8] Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
    Deprez, Pierre H.
    Moons, Leon M. G.
    O'Toole, Dermot
    Gincul, Rodica
    Seicean, Andrada
    Pimentel-Nunes, Pedro
    Fernandez-Esparrach, Gloria
    Polkowski, Marcin
    Vieth, Michael
    Borbath, Ivan
    Moreels, Tom G.
    van Dijkum, Els Nieveen
    Blay, Jean-Yves
    van Hooft, Jeanin E.
    [J]. ENDOSCOPY, 2022, 54 (04) : 412 - 429
  • [9] Management of type-I gastric neuroendocrine neoplasms: A 10-years prospective single centre study
    Esposito, Gianluca
    Cazzato, Maria
    Rinzivillo, Maria
    Pilozzi, Emanuela
    Lahner, Edith
    Annibale, Bruno
    Panzuto, Francesco
    [J]. DIGESTIVE AND LIVER DISEASE, 2022, 54 (07) : 890 - 895
  • [10] A "Watch and Wait" Strategy Involving Regular Endoscopic Surveillance Is Safe for Many Patients with Small, Sporadic, Grade 1, Non-Ampullary, Non-Functioning Duodenal Neuroendocrine Tumours
    Exarchou, Klaire
    Moore, Andrew R.
    Smart, Howard L.
    Duckworth, Carrie A.
    Howes, Nathan
    Pritchard, D. Mark
    [J]. NEUROENDOCRINOLOGY, 2021, 111 (08) : 764 - 774